Top Markets
Coin of the day
Nevro Corp. Nevro Corp.

Nevro Corp.

NVRO
株式のランク #17833
Nevro Corp. is a medical technology firm that delivers solutions for... Nevro Corp. is a medical technology firm that delivers solutions for individuals experiencing persistent pain, serving markets both domestically in the United States and across the globe. The company's core business involves the development and market introduction of the Senza spinal cord stimulation (SCS) system, an advanced, clinically supported neuromodulation platform specifically engineered to alleviate chronic pain. This portfolio encompasses its newer generations, the Senza II and Senza Omnia systems. Additionally, Nevro offers its proprietary 10 kHz Therapy, providing neuromodulation approaches grounded in robust clinical evidence for effective chronic pain management. Its products are distributed through a diverse strategy, utilizing a dedicated direct sales team complemented by a network of specialized sales agents and independent distributors. Founded in 2006, Nevro Corp. maintains its corporate headquarters in Redwood City, California.
株価
$5.84
最終同期: 2025-04-02
時価総額
$224.09M
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Nevro Corp. (NVRO)

カテゴリー

Nevro Corp.(NVRO)の営業利益率
September 2026 時点の営業利益率 TTM: -30.90%
Nevro Corp. の最新の財務報告と株価によると、現在の営業利益率(TTM)は -30.90% です。2023 年末時点では -23.36% でした。
Nevro Corp. の営業利益率の履歴(2012 から 2026)
各年末の営業利益率
営業利益率 変化
2026 (TTM) -30.90% 0.00%
2024 -30.90% 32.28%
2023 -23.36% -3.95%
2022 -24.32% 3.49%
2021 -23.50% 35.37%
2020 -17.36% -29.77%
2019 -24.72% 129.31%
2018 -10.78% 19.12%
2017 -9.05% -10.40%
2016 -10.10% -88.73%
2015 -89.60% 3.11%
2014 -86.90% -18.81%
2013 -107.03% 1.55%
2012 -105.40% 0.00%
同業他社の営業利益率
企業 営業利益率 営業利益率の差
17.03% -100.55%
US
22.03% -100.71%
US
17.86% -100.58%
IE
21.46% -100.69%
US
28.09% -100.91%
US
企業の営業利益率とは?
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。